BackImmix Biopharma Overview

Immix Biopharma Current Cash

Track Immix Biopharma's current cash ($230M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$225.49M
↑ 1837.56% YoYΔ $213.85M vs prior year quarter

Peer trimmed avg / median

Loading

Immix Biopharma Current Cash History

Loading

Immix Biopharma vs. peers: Current Cash Comparison

Loading

Immix Biopharma Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Immix Biopharma (IMMX) FAQ

Immix Biopharma (IMMX) currently reports a current cash of $230M as of June 2026. That compares with $12M in the prior-year period — up 1837.6% year over year. Use the charts on this page to explore Immix Biopharma's current cash history and peer comparisons.

Immix Biopharma's current cash increased from $12M to $230M — a 1837.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Immix Biopharma reported $230M in current cash as of June 2026. That compares with $12M in the prior-year period — up 1837.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $230M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Immix Biopharma, and consider following IMMX for alerts when major investors trade the stock.